Pfizer

Pfizer

Pfizer is an American, multinational pharmaceutical and biotechnology corporation.

Pfizer is an American, multinational pharmaceutical and biotechnology corporation. The company was founded in 1849, in New York, New York, United States.

Pfizer has the mission to fund programs that provide public benefit, advance medical care, and can improve patient outcomes. Their researchers preform 25,000 clinical tests everyday for pharmaceutical development and innovations.

Partnerships

BaseLaunch

Pfizer is a partner with the BaseLaunch startup accelerator. The BaseLaunch program receives applications in the fields of therapeutics, diagnostics, digital healthcare, healthcare services, therapeutic platforms, and medical technology.

Insilico Medicine

Insilico Medicine and Pfizer entered into a research collaboration agreement. The agreement allows Pfizer to utilize Insilico Medicine's machine learning technology and Pandomics Discovery Platform to research potential therapeutic targets for a variety of diseases.

AMRA Medical

AMRA Medical and Pfizer's partnership works to investigate body fat distribution and muscle composition in a range of diseases using the UK Biobank registry. The partnership involves the body composition analysis of 100,000 individuals.

CytoReason

Pfizer's partnership with CytoReason gives them access to CytoReason's machine learning platform for drug discovery and development.

XtalPi Inc.

XtalPi Inc. and Pfizer's research collaboration focuses on developing a hybrid physics-and artificial intelligence-powered software platform for accurate molecular modeling of small molecules. The platform is intended to advance both companies capabilities in drug design and solid-form selection.

Distributed Bio

Pfizer and Distributed Bio entered an agreement to license Distributed Bio's SuperHuman Platform to Pfizer. The SuperHuman 2.0 antibody discovery platform will allow Pfizer to utilize the antibody library for screening activities against Pfizer-selected targets.

Domain Therapeutics

Domain Therapeutics and Pfizer entered into a collaboration agreement to asses Domain Therapeutics's bioSensAll platform. The bioSensAll platform defines signaling signatures for each wild-type and mutant receptors. Pfizer aims to use the platform to assess the impact of mutations on different signaling pathways engaged by g protein-coupled receptors.

COVID-19

Pfizer announced that they have identified certain antiviral compounds that are under development which could be effective in treating the novel coronavirus SARS-CoV-2 responsible for COVID-19. They may enter a partnership with a third party company to screen and identify potential compounds by the end of March, 2020 in order to begin testing in April, 2020.

Pfizer is partnered with BioNTech for co-development and distribution of an mRNA vaccine against SARS-CoV-2 called BNT162.

Timeline

May 19, 2020

Pfizer and Adage bump up Amplyx's series C to top $90 million.

January 14, 2020

Insilico enters into research collaboration with Pfizer Inc. to explore novel data and artificial intelligence system for potential therapeutic targets.

August 21, 2019

Pfizer announces an additional half billion dollar investment for the construction of its gene therapy manufacturing facility in Sanford, North Carolina.

June 17, 2019

Pfizer acquires Array BioPharma for $11.4 billion.

March 20, 2019

Pfizer Inc. acquires option to buy Vivet Therapeutics for equivalent of $635.8 million.

January 7, 2019

CytoReason signs collaboration agreement with Pfizer Inc. to utilize CytoReason's machine learning model of the immune system for drug discovery.

September 12, 2018

Pfizer's subsidiary, Pfizer Ventures, participated in System1's Series A financing.

System1 stated they will use the funding to drive its drug discovery programs for autism, epilepsy, and schizophrenia. Their system uses robot automation for the development of organoids and uses data analysis systems to analyze the resulting data streams.

May 8, 2018

XtalPi Inc. announces research collaboration with Pfizer Inc. to develop artificial intelligence-powered molecular modeling technology for drug discovery.

May 8, 2018

Pfizer supports the Centre for Process Innovation (CPI) and their technology for process manufacturing and nano-formulated medicines.

Funded Companies

Company
Description
Industry
Website
Location
Molecular Stethoscope

A molecular diagnostics company developing novel blood-based early detection and disease monitoring tests based on analyzing circulating cell-free messenger RNA (cf-mRNA) in blood samples to monitor organ function.

Cortexyme is a biotechnology company with a focus on developing therapeutics for Alzheimer's disease and other neurodegenerative diseases. It was founded in 2012 and is located in San Francisco, California.

Trillium Therapeutics is a biotechnology company developing cancer immunotherapies.

Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs.

SpringWorks Therapeutics is a Stamford, Connecticut-based company founded in 2017 by Lara S. Sullivan.

FoRx Therapeutics is a Basel-based biotechnology company developing a drug discovery platform for cancer drugs.

A company developing therapies for cancer and immune disorders

Vivet Therapeutics is a France-based company.

Arrakis Therapeutics is a Waltham, Massachusetts-based company.

Imara is a Cambridge, Massachusetts-based company.

Strata is a Lake Forest, California-based company founded in 1995.

AnTolRx is a Cambridge, Massachusetts-based company.

Aquinnah Pharmaceuticals is a Cambridge, Massachusetts-based company.

NextCure is a Beltsville, Maryland-based company.

15 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

Products

Product
Description
Website
Launch date
Industry
Ondansetron

Chemical compound

315 Results
Page 1 of 13
...
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

A. Santiesteban

Employee

Abby Michaud

Employee

Abdalrahman Mekky, CMA

Employee

Abinaya A

Employee

Abiola Joseph

Employee

Abraham Svinkelstin, PMP, MS, MS, CSSGB

Employee

Adam Escalante

Employee

Adekunle Adeniran

Employee

Agnes Lei

Employee

AHMET ADIYAMAN

Employee

Aimee Greene

Employee

Aindréas MacDomhnaill

Employee

Aine Aherne

Employee

Akanqsha Shetty

Employee

Alba Hernandez

Employee

Alec Robert Gilarde

Employee

Alejandra Fonseca

Employee

Alekhya Reddy

Employee

Alex Haddad

Employee

Alexander H. Buell

Employee

Alexandra Grossbarth

Employee

Alexey Chapyshev

Employee

Alican Liceoglu

Employee

Alisha Dhiman

Employee

Alison Hanlon

Employee

Page 1 of 28
...

Further reading

Title
Author
Link
Type
Date

Breaking the Rules of Biology to Beat Rare Genetic Disease | Pfizer

Web

Our Science: Pharmaceutical Development | Pfizer | Pfizer

Web

Pfizer | Crunchbase

Web

Pfizer's Core Values of Social Responsibility and Philanthropy | Pfizer

Web

What to Know About Coronavirus -- COVID-19 Explained | Pfizer

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Pfizer

Alberta Bourla

New York, New York, United States

Medical, healthcare, biotechnology, and pharmaceutical products and services

News

Title
Author
Date
Publisher
Description
Beth Mole
September 8, 2020
Ars Technica
Trump denied politicizing vaccine but said it could arrive "before a very special date."
Charles Schmidt
August 25, 2020
Scientific American
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
Reuters
July 31, 2020
@bsindia
BioNTech and Pfizer on Monday began a large, late-stage trial of their vaccine candidate to demonstrate its efficacy
Agencies
July 28, 2020
@bsindia
The study is expected to include about 120 sites globally and could include up to 30,000 participants. It will include regions heavily impacted by Covid-19
SI Reporter
July 28, 2020
@bsindia
Heres a list of stocks that may remain in focus today.
Samreen Ahmad
July 27, 2020
@bsindia
Revenue stood at Rs 514.89 crore against Rs 544.40 crore for the same period a year ago
Reuters
July 22, 2020
@bsindia
The agreement allows the US government to acquire an additional 500 million doses
BS Web Team
July 21, 2020
@bsindia
There are 23 coronavirus vaccine candidates in human trials, including Moderna, AstraZeneca Plc, BioNTech, Novavax, Sinovac, CanSino Biologics and Inovio. Catch latest updates on Covid-19 vaccine
Ben Adams
July 15, 2020
FierceBiotech
Pfizer has signed up for a new three-year deal, with the option for this to be extended to five years, with CRO Syneos Health.
Alexi Cohan
July 13, 2020
Boston Herald
Two investigational coronavirus vaccine candidates from Pfizer and German company BioNTech received fast track approval from the Food and Drug Administration which will further facilitate the development process for a much-needed vaccine.
Reuters
July 13, 2020
@bsindia
If the ongoing studies are successful, and the vaccine candidate receives regulatory approval, the companies said they expect to make up to 100 million doses by the end of this year
July 9, 2020
BioSpace
Viatris Reveals Branding to Reflect New Company's Transformative Strategy - read this article along with other careers information, tips and advice on BioSpace
Ben Adams
July 6, 2020
FierceBiotech
Pfizer is deepening its already long-term investment and partnership strategy with U.K.-based biotech Mission Therapeutics and its work on selectively inhibiting deubiquitylating enzymes.
AP | PTI
July 2, 2020
@bsindia
With its other potential candidates still in the earliest stage of testing, Pfizer aims to open a large-scale study this summer but cant yet say which shot is best to include
Maryn McKenna
July 1, 2020
Wired
Developers need to test in hotspots, but those keep changing. And they must avoid ethical problems, like testing in low-income areas but only selling in rich ones.
Swati Verma
July 1, 2020
@bsindia
The eligibility of stock inclusion in the derivatives / F&O segment is based on the criteria laid down by market regulator Sebi.
Amirah Al Idrus
June 17, 2020
FierceBiotech
There's a pivotal trial in the offing for Pfizer and Sangamo's hemophilia A gene therapy, but, in the meantime, the duo is unveiling updated phase 1/2 data. The highest dose of the treatment helped patients make functioning blood-clotting factors for a sustained period, underlining its potential to free hemophilia A patients from lifelong treatment.
June 18, 2020
The Indian Express
Coronavirus (Covid-19) Vaccine Latest Update: Vaccines developed by Moderna Inc, China's Sinovac Biotech and UK's Oxford-AstraZeneca are set to enter late-stage trials in July and subject to large-scale studies.
Devansh Sharma
June 16, 2020
Livemint
Saudi Arabia's sovereign wealth fund, PIF, is all set to pick up 2.33% stake in Jio Platforms, Gulf News reported.Tata Motors reported a consolidated net loss of ₹9,863.75 crore for the January-March period of FY20
Mark Terry
June 11, 2020
BioSpace
According to the report, at least 17 of this year's 28 new drug shortages "are directly or indirectly prompted by events the current COVID-19 pandemic has brought on," which includes the increased demand for anesthetics and other drugs used to facilitate intubation.
SHOW MORE

References

Page 1 of 2
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.